| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.088 | 0.05 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.078 | 0.05 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.05 |